NCT07067736

Cefazolin Antibiotic Prophylaxis in Ventricular Shunt Surgery: Determination of Cerebrospinal Fluid Concentration During Valve Implantation

Cefazolin Antibiotic Prophylaxis in Ventricular Shunt Surgery: Determination of Cerebrospinal Fluid(CSF) Concentration During Valve Implantation

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: University Hospital, Strasbourg, France · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective is to determine the concentration of cefazolin in the cerebrospinal fluid after a recommended antiobiotic prophylaxis by 2g of cefazolin. Our main hypothesis is that the concentration is insufficient to protect the valve from infections. The secondary objective is to compare our results to known pharmacokinetic models of cefazolin diffusion in the literature. If differences are found we would like to search clinical features that could explain it.

Conditions

• Hydrocephaly
• CSF Shunts
• Antibiotic Prophylaxis

Interventions

Type	Name	Description
OTHER	Cefazolin antibiotic prophylaxis	Determination of cerebrospinal fluid concentration

Timeline

• Start date: 2025-08-01
• Primary completion: 2026-07-31
• Completion: 2026-08-30
• First posted: 2025-07-16
• Last updated: 2025-08-08

Locations

1 site across 1 country: France